Concepedia

Joachim Wernicke

JW

22

Publications

4.2K

Citations

18

H-Index

1971

Active since

Affiliations

Eli Lilly (United States)(Current)

Indiana University – Purdue University Indianapolis

Indiana University School of Medicine

Eli Lilly (Canada)

Massachusetts General Hospital

Joachim Wernicke is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and health sciences.

Top concepts

Publications per year

1971–2013

22

Publications

22

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies

David Michelson, Lenard A. Adler, Thomas Spencer et al. · Biological Psychiatry · 2003 · 787 citations

, , +7

Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Dose-Response Study

David Michelson, Douglas E. Faries, Joachim Wernicke et al. · PEDIATRICS · 2001 · 668 citations

Once-Daily Atomoxetine Treatment for Children and Adolescents With Attention Deficit Hyperactivity Disorder: A Randomized, Placebo-Controlled Study

David Michelson, Albert J. Allen, Joan Busner et al. · American Journal of Psychiatry · 2002 · 598 citations

A Double-Blind, Randomized Multicenter Trial Comparing Duloxetine with Placebo in the Management of Diabetic Peripheral Neuropathic Pain

Joel Raskin, Yili Pritchett, Fujun Wang et al. · Pain Medicine · 2005 · 527 citations · Full text

A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder

Lesley M. Arnold, A. Rosen, Yili Pritchett et al. · Pain · 2005 · 470 citations

, , +24

Rows per page

1–5 of 22